Lineage Cell Therapeutics
LCTX
LCTX
74 hedge funds and large institutions have $98.5M invested in Lineage Cell Therapeutics in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 13 closing their positions.
Holders
74
Holders Change
-6
Holders Change %
-7.5%
% of All Funds
2.07%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
18
Reduced
24
Closed
13
Calls
$113K
Puts
$508K
Net Calls
-$395K
Net Calls Change
-$2.97M
Top Buyers
1 |
BC
1
Broadwood Capital
New York
|
$60.8M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$5.17M |
3 |
3
Jane Street
New York
|
$376K |
4 |
V
4
Veritable
Wilmington,
Delaware
|
$465K |
5 |
SFA
5
Sequoia Financial Advisors
Akron,
Ohio
|
$135K |